HC Wainwright Reaffirms “Buy” Rating for Aemetis (NASDAQ:AMTX)

Aemetis (NASDAQ:AMTX)‘s stock had its “buy” rating reaffirmed by research analysts at HC Wainwright in a research note issued to investors on Monday,Benzinga reports. They presently have a $28.00 price objective on the specialty chemicals company’s stock.

Separately, Ascendiant Capital Markets dropped their target price on Aemetis from $20.00 to $19.00 and set a “buy” rating on the stock in a research report on Tuesday, September 3rd. One research analyst has rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $12.95.

Aemetis Trading Up 1.5 %

AMTX stock opened at $2.63 on Monday. The firm has a 50 day simple moving average of $3.30 and a 200-day simple moving average of $2.99. The company has a market capitalization of $130.80 million, a P/E ratio of -1.16 and a beta of 1.35. Aemetis has a twelve month low of $2.10 and a twelve month high of $7.03.

Aemetis (NASDAQ:AMTX) last released its quarterly earnings data on Tuesday, November 12th. The specialty chemicals company reported ($0.38) EPS for the quarter, topping analysts’ consensus estimates of ($0.47) by $0.09. The business had revenue of $81.44 million during the quarter, compared to analyst estimates of $77.79 million. During the same period in the prior year, the firm earned ($0.59) EPS. On average, research analysts predict that Aemetis will post -2.02 EPS for the current year.

Hedge Funds Weigh In On Aemetis

Large investors have recently bought and sold shares of the stock. Bank of New York Mellon Corp acquired a new position in Aemetis during the second quarter worth about $306,000. Rhumbline Advisers raised its position in shares of Aemetis by 2,837.1% during the second quarter. Rhumbline Advisers now owns 52,309 shares of the specialty chemicals company’s stock worth $157,000 after purchasing an additional 50,528 shares during the period. Hutchinson Capital Management CA purchased a new stake in shares of Aemetis during the second quarter valued at $70,000. Susquehanna Fundamental Investments LLC boosted its position in shares of Aemetis by 287.4% in the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 126,078 shares of the specialty chemicals company’s stock valued at $379,000 after purchasing an additional 93,536 shares during the period. Finally, FMR LLC increased its position in shares of Aemetis by 68.2% in the third quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock worth $52,000 after acquiring an additional 9,137 shares in the last quarter. Institutional investors and hedge funds own 27.02% of the company’s stock.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.